228 related articles for article (PubMed ID: 32624384)
21. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
22. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series.
Wojcik JB; Bellizzi AM; Dal Cin P; Bredella MA; Fletcher CD; Hornicek FJ; Deshpande V; Hornick JL; Nielsen GP
Am J Surg Pathol; 2014 Nov; 38(11):1538-44. PubMed ID: 24921641
[TBL] [Abstract][Full Text] [Related]
24. Sclerosing Epithelioid Fibrosarcoma of the Bone With Rare EWSR1-CREB3L3 Translocation Driving Upregulation of the PI3K/mTOR Signaling Pathway.
Shenoy A; Surrey L; Jain P; Foster J; Straka J; Resnick A; Waanders A; Luo M; Li M; Kazahaya K; Bagatell R; Wojcik J; Pogoriler J
Pediatr Dev Pathol; 2019; 22(6):594-598. PubMed ID: 31335288
[TBL] [Abstract][Full Text] [Related]
25. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
26. Primary Sclerosing Epithelioid Fibrosarcoma of the Kidney: A Case Report and Review of the Literature.
Peng Y; Chen T; Zhang D; Wu C; Lei T; Shi Y; Xia C; Li Q
Int J Surg Pathol; 2022 Jun; 30(4):437-442. PubMed ID: 34894816
[TBL] [Abstract][Full Text] [Related]
27. Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor.
Murshed KA; Al-Bozom I; Ammar A
APMIS; 2021 Aug; 129(8):455-460. PubMed ID: 34048081
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing Epithelioid Fibrosarcoma of the Liver in a Pediatric Patient.
Armstrong A; Boulos F; Kulkarni S; Stoll J; Doyle MBM; Khan A; He M
Pediatr Dev Pathol; 2023; 26(2):153-160. PubMed ID: 36748108
[TBL] [Abstract][Full Text] [Related]
29. Primary sclerosing epithelioid fibrosarcoma of the kidney: Report of two additional cases with a clinicopathological and molecular cytogenetic study.
Wang X; Wang J
Exp Mol Pathol; 2019 Apr; 107():179-183. PubMed ID: 30825419
[TBL] [Abstract][Full Text] [Related]
30. Cytomorphologic findings of low-grade fibromyxoid sarcoma.
Mustafa S; VandenBussche CJ; Ali SZ; Siddiqui MT; Wakely PE
J Am Soc Cytopathol; 2020; 9(3):191-201. PubMed ID: 32197967
[TBL] [Abstract][Full Text] [Related]
31. Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.
Rekhi B; Folpe AL; Deshmukh M; Jambhekar NA
Pathol Oncol Res; 2011 Mar; 17(1):145-8. PubMed ID: 20499220
[TBL] [Abstract][Full Text] [Related]
32. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
33. Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.
Suster DI; Gross JM; Fayad L; Wenokor C; Goldsmith JD; Ward A; Early C; Lazano-Calderon S; Klein MJ
Skeletal Radiol; 2024 Feb; 53(2):387-393. PubMed ID: 37524934
[TBL] [Abstract][Full Text] [Related]
34. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
35. Metastatic Sclerosing Epithelioid Fibrosarcoma in Bone Marrow.
Asakra R; Zaidi S; Thway K
Int J Surg Pathol; 2017 Dec; 25(8):702-704. PubMed ID: 28697683
[TBL] [Abstract][Full Text] [Related]
36. Sclerosing Epithelioid Fibrosarcoma of the Jaw: Late Recurrence from a Low Grade Fibromyxoid Sarcoma.
Laliberte C; Leong IT; Holmes H; Monteiro EA; O'Sullivan B; Dickson BC
Head Neck Pathol; 2018 Dec; 12(4):619-622. PubMed ID: 29274042
[TBL] [Abstract][Full Text] [Related]
37. FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma.
Wang WL; Evans HL; Meis JM; Liegl-Atzwanger B; Bovee JV; Goldblum JR; Billings SD; Rubin BP; López-Terrada D; Lazar AJ
Mod Pathol; 2012 Jun; 25(6):846-53. PubMed ID: 22388756
[TBL] [Abstract][Full Text] [Related]
38. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
Thway K; Ng W; Benson C; Chapman J; Fisher C
Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
[TBL] [Abstract][Full Text] [Related]
39. The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature.
Peng Y; Zhang D; Lei T; Xie J; Wu C; Wang H; Shi Y; Li Q; Wang J
Pathology; 2023 Apr; 55(3):355-361. PubMed ID: 36690575
[TBL] [Abstract][Full Text] [Related]
40. Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion.
Stockman DL; Ali SM; He J; Ross JS; Meis JM
Hum Pathol; 2014 Oct; 45(10):2173-8. PubMed ID: 25123073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
